EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 272 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,840,000 | -20.5% | 36,749 | 0.0% | 0.21% | -19.8% |
Q2 2021 | $2,315,000 | -32.2% | 36,749 | 0.0% | 0.26% | -33.9% |
Q1 2021 | $3,414,000 | +3.7% | 36,749 | 0.0% | 0.39% | -3.7% |
Q4 2020 | $3,293,000 | -13.3% | 36,749 | 0.0% | 0.40% | -27.5% |
Q3 2020 | $3,797,000 | +113.7% | 36,749 | +63.6% | 0.56% | +101.1% |
Q2 2020 | $1,777,000 | +36.7% | 22,467 | 0.0% | 0.28% | +12.6% |
Q1 2020 | $1,300,000 | +12900.0% | 22,467 | +10967.5% | 0.25% | +12200.0% |
Q1 2019 | $10,000 | -16.7% | 203 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $12,000 | -55.6% | 203 | -50.1% | 0.00% | -50.0% |
Q3 2018 | $27,000 | +28.6% | 407 | 0.0% | 0.00% | +33.3% |
Q2 2018 | $21,000 | 0.0% | 407 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $21,000 | +10.5% | 407 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $19,000 | +18.8% | 407 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $16,000 | +14.3% | 407 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $14,000 | +16.7% | 407 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $12,000 | – | 407 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |